Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya (6-12 Month RCT).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Abacavir; Lamivudine; Lopinavir/ritonavir; Nevirapine; Stavudine; Zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- 27 Aug 2018 Biomarkers information updated
- 22 Sep 2009 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.